FDA Panel Mulls Child Medicine Crackdown

Law360, New York (October 18, 2007, 12:00 AM EDT) -- A week after numerous drug makers pulled infant cough and cold medicines off shelves, expert advisers to the U.S. Food and Drug Administration kicked off meetings today to discuss a petition that would ban such over-the counter medicines for children below the age of 6.

An FDA public advisory committee was scheduled to hear from an array of medical professionals on Thursday. The professionals were expected to urge the panel to take seriously the dangers associated with the decongestant remedies for young children.

The citizen petition,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.